Published in Medical Letter on the CDC and FDA, October 20th, 1997
The finding comes from a study by the U.S. Centers for Disease Control and Prevention (CDC) that assessed implementation of U.S. Public Health Service (PHS) recommendations. In August 1994, the PHS recommended AZT use for all pregnant women with HIV infection, and in 1995 added routine counseling and voluntary testing to its standard of obstetric care.
"Increasing proportions of mothers and newborns are receiving AZT, resulting in fewer infants becoming HIV infected," said Mary Lou...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA